Table 4.
Summary of association between six selected SNP markers and testicular germ cell tumor
Gene | Marker | Nonrisk/risk | RAF |
Per Allele OR (95% CI) |
Width of CI |
|||
---|---|---|---|---|---|---|---|---|
Allele | Controls | Cases | PCA | PCAPS | PCA | PCAPS | ||
KITLG | rs4474514 | A/G | 0.802 | 0.899 | 2.33 (1.68–3.24) | 2.03 (1.48–2.79) | 1.56 | 1.31 |
rs3782181 | T/G | 0.798 | 0.894 | 2.21 (1.61–3.05) | 1.95 (1.43–2.66) | 1.44 | 1.23 | |
rs1472899 | T/C | 0.801 | 0.897 | 2.18 (1.58–3.00) | 1.92 (1.41–2.62) | 1.43 | 1.21 | |
rs3782179 | A/G | 0.802 | 0.896 | 2.22 (1.61–3.07) | 1.95 (1.43–2.67) | 1.46 | 1.24 | |
rs11104952 | C/A | 0.802 | 0.896 | 2.22 (1.60–3.05) | 1.95 (1.43–2.65) | 1.45 | 1.23 |
Marker, dbSNP rs number; RAF, risk allele frequency; OR, odds ratio; CI, confidence interval; PCA, principal components analysis; PCAPS, principal components and propensity score.